EU Chief Spokesman Eric Mamer told a news conference in Brussels on Thursday that Germany’s talks on the Russian vaccine, Sputnik, could be used to buy and use vaccines other than the EU’s vaccination strategy for EU member states to vaccinate their citizens. This is memorable: when Hungary signed a treaty, the Union “warned” against it.
When asked about Germany’s announcement on Thursday that it would begin talks with Russia on the Sputnik V vaccine against a new type of corona virus (SARS-CoV-2) on a bilateral basis independently from the European Union, Eric Mமர்mer responded: ” There is a chance.
This is not the end of the EU’s vaccination strategy he said.
However he acknowledged that their numbers were not enough to defeat President Conte’s government, but said that maintaining some independence was not the answer.
The European Commission has so far identified Johnson & Johnson (400 million doses), Biotech-Pfizer (600 million doses), Moderna (460 million doses), Astrogeneca (400 million doses), Curvac (405 million doses) and Sanofi. -GSK (300 million dose) has signed an agreement to purchase vaccines.
EU Commission Spokesman Stephen de Geersmaker stressed at the press conference that the most important thing for the EU body is to bring safe vaccines to the EU market. However, vaccination and immunization campaigns are a matter for member states He added.
The European Pharmaceuticals Association (EMA) makes important discoveries about the safety and efficacy of vaccines, but since vaccination policy is a member state capacity, member states may decide to adopt a tougher approach to vaccines than EMA recommendations.
However, he warned that the decision of one member state could affect other member states. Since the vaccine policy is a member state capability, it can be determined based on the needs of that organ state and its own epidemiological situation, he said.